Skip to content

Daniel Robert Bamrick-Fernandez, MD, MBA

NPI 1063113678ActiveIndividual· Dermatology· Chicago, IL

Dermatology (MD, MBA) in Chicago, Illinois, licensed in IL, with an NPI issued in March 2023. Part D covered 12 prescriptions written in 2024, 92% of them generic. Genzyme Corporation was the largest of 13 companies reporting payments in 2025, $1,482 in all, mostly food and beverage.

Overview

NPI1063113678
StatusActive
Entity typeIndividual
CredentialMD, MBA
Sole proprietorNo
NPI issuedMar 13, 2023
Last updated in NPPESJul 7, 2025
Certified by providerJul 7, 2025

Specialties and licenses

TaxonomyCodeLicenseState
Dermatology Primary207N00000X125.084285IL

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Dermatology (IL)

Part D prescriptions in 2024

Prescriptions (claims)12 · 15 30-day fills
Total drug cost$1,406
Generic share92% of claims

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$1,482 · 25 payments from 13 companies
  • 2024$141.64 · 1 payment from 1 company

Top paying companies in 2025

What the 2025 payments were for

  • Food and Beverage$1,213 · 22 payments
  • Education$268.98 · 3 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Dermatology providers in Chicago

All Dermatology providers in Illinois →